X-136206125-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001159702.3(FHL1):c.-26-282A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00792 in 411,915 control chromosomes in the GnomAD database, including 71 homozygotes. There are 891 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.021 ( 51 hom., 669 hem., cov: 23)
Exomes 𝑓: 0.0031 ( 20 hom. 222 hem. )
Consequence
FHL1
NM_001159702.3 intron
NM_001159702.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.133
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-136206125-A-G is Benign according to our data. Variant chrX-136206125-A-G is described in ClinVar as [Benign]. Clinvar id is 669527.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0669 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.23-282A>G | intron_variant | ENST00000370683.6 | |||
FHL1 | NM_001159702.3 | c.-26-282A>G | intron_variant | ENST00000394155.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.23-282A>G | intron_variant | 1 | NM_001159699.2 | P1 | |||
FHL1 | ENST00000394155.8 | c.-26-282A>G | intron_variant | 5 | NM_001159702.3 |
Frequencies
GnomAD3 genomes AF: 0.0208 AC: 2348AN: 112818Hom.: 51 Cov.: 23 AF XY: 0.0191 AC XY: 668AN XY: 34970
GnomAD3 genomes
AF:
AC:
2348
AN:
112818
Hom.:
Cov.:
23
AF XY:
AC XY:
668
AN XY:
34970
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00306 AC: 916AN: 299045Hom.: 20 Cov.: 0 AF XY: 0.00231 AC XY: 222AN XY: 96099
GnomAD4 exome
AF:
AC:
916
AN:
299045
Hom.:
Cov.:
0
AF XY:
AC XY:
222
AN XY:
96099
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0208 AC: 2348AN: 112870Hom.: 51 Cov.: 23 AF XY: 0.0191 AC XY: 669AN XY: 35032
GnomAD4 genome
AF:
AC:
2348
AN:
112870
Hom.:
Cov.:
23
AF XY:
AC XY:
669
AN XY:
35032
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at